This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Colibri Photonics Gmbh, Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2017.
Company Filing History:
1 out of 1 
1 out of 4,920 
1 out of 911 
Years Active: 2017
Title: The Innovations of Danny Bavli
Introduction
Danny Bavli is an accomplished inventor based in Jerusalem, Israel. He has made significant contributions to the field of biotechnology, particularly in the area of monitoring physiological parameters in cells. His innovative approach has the potential to impact various medical applications.
Latest Patents
Bavli holds a patent for a "Method and system for continuous monitoring of toxicity." This patent encompasses systems, kits, and methods for non-invasive, long-term, real-time monitoring of one or more physiological parameters of a cell, including but not limited to oxygen uptake. This invention represents a significant advancement in the ability to monitor cellular health and toxicity levels.
Career Highlights
Throughout his career, Danny Bavli has worked with notable organizations, including Colibri Photonics GmbH and Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. His experience in these companies has allowed him to develop and refine his innovative ideas in the field of biotechnology.
Collaborations
Bavli has collaborated with esteemed colleagues such as Yaakov Nahmias and Elmar Schmälzlin. These partnerships have fostered a creative environment that has led to groundbreaking advancements in their respective fields.
Conclusion
Danny Bavli's contributions to the field of biotechnology through his innovative patent and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in non-invasive monitoring techniques.